February 28, 2015 8:22 AM ET

Capital Markets

Company Overview of Atlas Venture L.P.

Executive Profile

Ankit Mahadevia M.D., MBA

President, Acting CBO, and Director, Spero Therapeutics, LLC
AgeTotal Calculated CompensationThis person is connected to 6 Board Members in 6 different organizations across 10 different industries.

See Board Relationships


Dr. Ankit Mahadevia, M.D., MBA is a Co-Founder at Synlogic, Inc. and has been its President and Director since July 22, 2014. He is an Entrepreneur-In-Residence, Venture Partner, and Partner at Atlas Venture L.P. Dr. Mahadevia joined the firm in 2008 and focuses on the life sciences sector, novel drug discovery platforms, therapeutic products, and other medical technologies that meet a significant unmet clinical need. Dr. Mahadevia served as a Principal at Atlas Venture. ...

Corporate Headquarters

25 First Street
Cambridge, Massachusetts 02141

United States

Phone: 617-588-2600
Fax: 617-588-2601

Board Members Memberships

Board Observer
President, Acting CBO, and Director
Co-Founder, President and Director


Johns Hopkins School of Medicine
University of Pennsylvania - The Wharton School
Northwestern University

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup


There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Atlas Venture L.P., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.